Pediatric reference intervals: Challenges and recent initiatives

Critical Reviews in Clinical Laboratory Sciences

Volumn 50, Issue 2, 2013, Pages 37-50

  Shaw, Julie L V ^a,b   Binesh Marvasti, Tina ^a   Colantonio, David ^a   Adeli, Khosrow ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Children; Disease biomarkers; Laboratory analytes; Pediatric; Reference interval

Indexed keywords

ADIPONECTIN; ALPHA AMYLASE PANCREAS ISOENZYME; ALPHA FETOPROTEIN; AMYLASE; ANDROGEN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM; CD30 ANTIGEN; CERULOPLASMIN; CREATINE KINASE; CREATININE; CYSTATIN C; DIPEPTIDYL PEPTIDASE IV; FOLLITROPIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GHRELIN; GLYCOSAMINOGLYCAN; HEMOGLOBIN; HYDROCORTISONE; IMMUNOGLOBULIN E; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PREALBUMIN; THYROTROPIN; URIC ACID;

ACUTE KIDNEY FAILURE; ANDROGEN BLOOD LEVEL; BRAIN DEVELOPMENT; BRAIN HYPOXIA; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; COMPUTER PROGRAM; DIARRHEA; HEAD INJURY; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE UNIT; LINEAR REGRESSION ANALYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATHEMATICAL ANALYSIS; METABOLIC SYNDROME X; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SAMPLE SIZE; SEX DIFFERENCE; STATISTICAL MODEL;

BIOLOGICAL MARKERS; CHILD; HUMANS; PEDIATRICS; REFERENCE VALUES;

EID: 84878995449     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2013.786673     Document Type: Review

References (121)

1. CLSI. Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008
2. Adeli K. Closing the gaps in paediatric reference intervals: the CALIPER initiative. Clin Biochem 2011;44:480-2
3. Schnabl K, Chan MK, Adeli K. Paediatric reference intervals: critical gap analysis and establishment of a national initiative. Clin Biochem 2006;39:559-60
4. Ferre-Masferrer M, Fuentes-Arderiu X, Alvarez-Funes V, et al. Multicentric reference values: shared reference limits. Eur J Clin Chem Clin Biochem 1997;35:715-8 (Pubitemid 27453370)
5. Ferre-Masferrer M, Fuentes-Arderiu X, Goma-Llongueras M, et al. Regional reference values for some quantities measured with the ADVIA Centaur analyser. A model of co-operation between the in vitro diagnostic industry and clinical laboratories. Clin Chem Lab Med 2001;39:166-9 (Pubitemid 32318482)
6. Fuentes-Arderiu X, Alonso-Gregorio E, Alvarez-Funes V, et al. Multicentre physiological reference intervals for serum concentrations of immunoglobulins A, G and M, complement C3c and C4 measured with Tina-Quant reagents systems. Clin Chem Lab Med 2007;45:387-90 (Pubitemid 46480901)
7. Fuentes-Arderiu X, Mas-Serra R, No-Lengaran C, et al. Multicentre physiological reference values for some urinary component-to-creatinine (creatininium) concentration ratios. Clin Chem Lab Med 2005;43:958-62 (Pubitemid 41461147)
8. Rustad P, Felding P, Franzson L, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64: 271-84
9. Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009;46:8-17
10. Ceriotti F. Establishing paediatric reference intervals: a challenging task. Clin Chem 2012;58:808-10
11. Colantonio D, Kyriakopoulou L, Chan MK, et al. Closing the gaps in Paediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854-68
12. Reed A, Henry R, Mason W. Influence of statistical method used on the resulting estimate of normal range. Clin Chem 1971;17: 275-84
13. Hawkins D. Encyclopedia of Statistical Sciences. New York: Wiley, 1985:539-43
14. Rorabacher D. Statistical treatment for rejection of deviant values: critical values of Dixon's ''Q'' parameter and related subrange ratios at the 95% confidence level. Anal Chem 1991; 63:139-146
15. Tukey J. Exploratory Data Analysis. Reading, MA: Addison- Wesley, 1977:688.
16. Hubert M, Van der Veeken S. Outlier detection for skewed data. J Chemometrics 2008;22:235-46
17. Sinton T, Cowley D, Bryant S. Reference intervals for calcium, phosphate, and alkaline phosphatase as derived on the basis of multichannel-analyzer profiles. Clin Chem 1986;32:76-9 (Pubitemid 17033781)
18. Harris E, Boyd J. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990;36:265-70
19. Healy M, Rasbash J, Yang M. Distribution-free estimation of age-related centiles. Ann Hum Biol 1988;15:17-22 (Pubitemid 18039850)
20. Virtanen A, Kairisto V, Irjala K, et al. Regression-based reference limits and their reliability: example on hemoglobin during the first year of life. Clin Chem 1998;44:327-35 (Pubitemid 28087732)
21. Horn P, Pesce A. Reference intervals: an update. Clin Chim Acta 2003;334:5-23 (Pubitemid 36836056)
22. Horn P, Pesce A, Copeland B. A robust approach to reference interval estimation and evaluation. Clin Chem 1998;44: 622-31 (Pubitemid 28141361)
23. Efron, B. Bootstrap methods: another look at the jackknife. Annal Stats 2012;7:1-26
24. Solberg H. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004;42: 710-4 (Pubitemid 39137218)
25. Harris E, DeMets D. Estimation of normal ranges and cumulative proportions by transforming observed distributions to gaussian form. Clin Chem 1972;18:605-12
26. Solberg H. International Federation of Clinical Chemistry. Scientific committee, Clinical Section. Expert Panel on Theory of Reference Values and International Committee for Standardization in Haematology Standing Committee on Reference Values. Approved recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. Clin Chim Acta 1987;165:111-8
27. Wright E, Royston P. Calculating reference intervals for laboratory measurements. Stat Methods Med Res 1999;8:93-112 (Pubitemid 29425898)
28. Estey M, Cohen A, Colantonio D, et al. CLSI-based transference of the CALIPER database of pediatric reference intervals: direct validation using reference samples from the CALIPER cohort. Clin Biochem 2013. [Epub ahead of print].
29. Hoffmann R. Statistics in the practice of medicine. JAMA 1963; 185:864-73
30. Katayev A, Balciza C, Seccombe D. Establishing reference intervals for clinical laboratory test results: is there a better way? Am J Clin Pathol 2010;133:180-6
31. Shaw J, Konforte D, Binesh-Marvasti T, et al. Validity of calculating pediatric reference intervals using hospital patient data: a comparison of the modified Hoffman approach to CALIPER reference intervals obtained in healthy children. Manuscript submitted for publication.
32. Schnabl K, Chan MK, Gong Y, Adeli K. Closing the gaps in paediatric reference intervals: the CALIPER initiative. Clin Biochem Rev 2008;29:89-96
33. Mansoub S, Chan MK, Adeli K. Gap analysis of paediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome. Clin Biochem 2006;39:569-87
34. Cheillan D, Vercherat M, Chevalier-Porst F, et al. False-positive results in neonatal screening for cystic fibrosis based on a threestage protocol (IRT/DNA/IRT): should we adjust IRT cut-off to ethnic origin? J Inherit Metab Dis 2005;28:813-8 (Pubitemid 43168916)
35. Eller L, Eller M, Ouma B, et al. Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials. PLoS One 2008;3:e3919.
36. Jung B, Adeli K. Clinical laboratory reference intervals in paediatrics: the CALIPER initiative. Clin Biochem 2009;42: 1589-95
37. Droke E, Kennedy T, Hubbs-Tait L. Potential for misclassification of micronutrient status in children participating in a Head Start program. J Am Diet Assoc 2006;106:376-82 (Pubitemid 43288013)
38. Ogunkeye O, Roluga A, Khan F. Resetting the detection level of cord blood thyroid stimulating hormone (TSH) for the diagnosis of congenital hypothyroidism. J Trop Pediatr 2008;54:74-7 (Pubitemid 351234414)
39. American Academy of Pediatrics AAP Section on Endocrinology and Committee on Genetics, and American Thyroid Association Committee on Public Health. Newborn screening for congenital hypothyroidism: recommended guidelines. Paediatrics 1993;91: 1203-9
40. Crofton P, Evans N, Taylor M, Holland C. Serum CrossLaps: paediatric reference intervals from birth to 19 years of age. Clin Chem 2002;48:671-3 (Pubitemid 34261239)
41. Slev P, Bunker A, Owen W, Roberts W. Paediatric reference intervals for random urine calcium, phosphorus and total protein. Pediatr Nephrol 2010;25:1707-10
42. Kushnir M, Blamires T, Rockwood A, et al. Liquid chromatography- tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with paediatric and adult reference intervals. Clin Chem 2010;56:1138-47
43. Clifford S, Bunker A, Jacobsen J, Roberts W. Age and gender specific paediatric reference intervals for aldolase, amylase, ceruloplasmin, creatine kinase, pancreatic amylase, prealbumin, and uric acid. Clin Chim Acta 2011;412:788-90
44. La'ulu S, Rasmussen K, Roberts W. Paediatric reference intervals for serum alpha-fetoprotein. Clin Chim Acta 2011;412: 1695-6
45. Lin C, Wilson A, Church B, et al. Paediatric reference intervals for serum copper and zinc. Clin Chim Acta 2012;413:612-5
46. Soldin O, Hoffman E, Waring M, Soldin S. Paediatric reference intervals for FSH, LH, estradiol, T3, free T3, cortisol, and growth hormone on the DPC IMMULITE 1000. Clin Chim Acta 2005; 355:205-10
47. Soldin O, Dahlin J, Gresham E, et al. IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone. Clin Biochem 2008;41:937-42
48. Soldin O, Bierbower L, Choi J, et al. Serum iron, ferritin, transferrin, total iron binding capacity, hs-CRP, LDL cholesterol and magnesium in children; new reference intervals using the Dade Dimension Clinical Chemistry System. Clin Chim Acta 2004;342:211-7 (Pubitemid 38352931)
49. Soldin O, Sharma H, Husted L, Soldin S. Paediatric reference intervals for aldosterone, 17alpha-hydroxyprogesterone, dehydroepiandrosterone, testosterone and 25-hydroxy vitamin D3 using tandem mass spectrometry. Clin Biochem 2009;42:823-7
50. Soldin S, Cheng L, Lam L, et al. Comparison of FT4 with log TSH on the Abbott Architect ci8200: paediatric reference intervals for free thyroxine and thyroid-stimulating hormone. Clin Chim Acta 2010;411:250-2
51. Soldin O, Jang M, Guo T, Soldin S. Paediatric reference intervals for free thyroxine and free triiodothyronine. Thyroid 2009;19: 699-702
52. Soldin S, Soldin O, Boyajian A, Taskier M. Paediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 2006;366:304-8 (Pubitemid 43331000)
53. Blasutig I, Jung B, Kulasingam V, et al. Analytical evaluation of the VITROS 5600 Integrated System in a paediatric setting and determination of paediatric reference intervals. Clin Biochem 2010;43:1039-44
54. Yip P, Chan MK, Nelken J, et al. Paediatric reference intervals for lipids and apolipoproteins on the VITROS 5,1 FS Chemistry System. Clin Biochem 2006;39:978-83 (Pubitemid 44444962)
55. Kulasingam V, Jung B, Blasutig I, et al. Paediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas 6000 analyzer - a CALIPER pilot study. Clin Biochem 2010;43: 1045-50
56. Brinc D, Chan MK, Venner A, et al. Long-term stability of biochemical markers in paediatric serum specimens stored at -80 degrees C: a CALIPER substudy. Clin Biochem 2012;45:816-26
57. Kohse K, Thamm M. KiGGS-the German survey on children's health as data base for reference intervals. Clin Biochem 2011;44: 479.
58. Ridefelt P, Aldrimer M, Rodoo P, et al. Population-based paediatric reference intervals for general clinical chemistry analytes on the Abbott Architect ci8200 instrument. Clin Chem Lab Med 2012;50:845-51
59. Southcott E, Kerrigan J, Potter J, et al. Establishment of paediatric reference intervals on a large cohort of healthy children. Clin Chim Acta 2010;411:1421-7
60. Aldrimer M, Ridefelt P, Rodoo P, et al. Reference intervals on the Abbot Architect for serum thyroid hormones, lipids and prolactin in healthy children in a population-based study. Scand J Clin Lab Invest 2012;72:326-32
61. Zec I, Kucak I, Begcevic I, et al. Reference intervals for reproductive hormones in prepubertal children on the automated Roche cobas e 411 analyzer. Clin Biochem 2012;45:1206-12
62. May A, Kuklina E, Yoon P. Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Paediatrics 2012; 129:1035-41
63. Tamimi W, Tamim H, Felimban N, et al. Age- and genderspecific reference intervals for serum lipid levels (measured with an Advia 1650 analyzer) in school children. Pediatr Int 2011;53:814-9
64. Liao Y, Mi J, Wang Y, et al. Study on the reference values of serum lipids in children aged 3-18 years old in Beijing, China. Pediatr Int 2010;52:472-9
65. Jolliffe C, Janssen I. Age-specific lipid and lipoprotein thresholds for adolescents. J Cardiovasc Nurs 2008;23:56-60
66. Daniels S, Greer F. Lipid screening and cardiovascular health in childhood. Paediatrics 2008;122:198-208
67. Kavey R, Allada V, Daniels S, et al. Cardiovascular risk reduction in high-risk paediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006;114:2710-38
68. Sveger T, Fex G. Apolipoprotein A-I and B levels in adolescents; a trial to define subjects at risk for coronary heart disease. Acta Paediatr Scand 1983;72:499-504 (Pubitemid 13062859)
69. Rifai N, Dufour D, Cooper G. Preanalytical variation in lipid, lipoprotein and apolipoprotein testing. In: Rifai N, Warnick G, Dominiczak M, eds. Handbook of Lipoprotein Testing. Washington, DC: AACC Press, 2000:161-77
70. Kottke B, Moll P, Michels V, Weidman W. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc 1991;66:1198-208
71. Bachorik P, Lovejoy K, Carroll M, Johnson C. Apolipoprotein B and AI distributions in the United States, 1988-1991: results of the National Health and Nutrition Examination Survey III (NHANES III). Clin Chem 1997;43:2364-78 (Pubitemid 28022974)
72. Wald N, Law M, Watt H, et al. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet 1994;343: 75-9 (Pubitemid 24019347)
73. Bao W, Srinivasan S, Berenson G. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 1996;93:54-9 (Pubitemid 26006568)
74. Chevenne D, Trivin F, Porquet D. Insulin assays and reference values. Diabetes Metab 1999;25:459-76 (Pubitemid 30003159)
75. Shea S, Aymong E, Zybert P, et al. Fasting plasma insulin modulates lipid levels and particle sizes in 2- to 3-year-old children. Obes Res 2003;11:709-21 (Pubitemid 41151597)
76. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372: 425-32 (Pubitemid 24365442)
77. Beltowski J. Adiponectin and resistin - new hormones of white adipose tissue. Med Sci Monit 2003;9:RA55-61 (Pubitemid 36330378)
78. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83 (Pubitemid 29299050)
79. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-6 (Pubitemid 30005109)
80. Steinberg D. The fate of plasma free fatty acids and their effects on tissue metabolism. Metabolism 1964;13:1264-72
81. Reaven G, Hollenbeck C, Jeng C, et al. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37:1020-4 (Pubitemid 19033579)
82. Bonnefont J, Specola N, Vassault A, et al. The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 1990;150:80-5
83. Broglio F, Arvat E, Benso A, et al. Ghrelin: endocrine and nonendocrine actions. J Pediatr Endocrinol Metab 2002;15:1219-27
84. Tschop M, Wawarta R, Riepl R, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001;24: RC19-21 (Pubitemid 32573786)
85. Becker A, Grinspoon S, Klibanski A, Herzog D. Eating disorders. N Engl J Med 1999;340:1092-8
86. Katugampola S, Davenport A. Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan. Br J Pharmacol 2001;134:1385-92 (Pubitemid 33131888)
87. Whatmore A, Hall C, Jones J, et al. Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol (Oxf) 2003;59: 649-54 (Pubitemid 37357628)
88. Smith J, Goetze J, Andersen C, Vejlstrup N. Practical application of natriuretic peptides in paediatric cardiology. Cardiol Young 2010;20:353-63
89. Choi B, Lee K, Eun B, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Paediatrics 2005;115:e255-61
90. Lindblade C, Chun D, Darragh R, et al. Value of plasma B-type natriuretic peptide as a marker for rejection in paediatric heart transplant recipients. Am J Cardiol 2005;95:909-11 (Pubitemid 40386814)
91. Khositseth A, Manop J, Khowsathit P, et al. N-terminal pro-brain natriuretic peptide as a marker in follow-up patients with tetralogy of Fallot after total correction. Pediatr Cardiol 2007;28:333-8 (Pubitemid 47415590)
92. Haase M, Haase-Fielitz A. NGAL - from discovery to a new era of "acute renal disease" diagnosis? Clin Biochem 2011;44:499-500
93. Trachtman H, Christen E, Cnaan A, et al. Urinary neutrophil gelatinase-associated lipocalcin in DHUS: a novel marker of renal injury. Pediatr Nephrol 2006;21:989-94 (Pubitemid 43885099)
94. Huynh T, Bateman D, Parravicini E, et al. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res 2009;66:528-32
95. Randers E, Krue S, Erlandsen E, et al. Reference interval for serum cystatin C in children. Clin Chem 1999;45:1856-8 (Pubitemid 29477346)
96. Grubb A. Cystatin C- and creatinine-based GFR-prediction equations for children and adults. Clin Biochem 2011;44:501-2
97. Armangil D, Yurdakok M, Canpolat FE, et al. Determination of reference values for plasma cystatin C and comparison with creatinine in premature infants. Pediatr Nephrol 2008;23:2081-3
98. Groesbeck D, Kottgen A, Parekh R, et al. Age, gender, and race effects on cystatin C levels in US adolescents. Clin J Am Soc Nephrol 2008;3:1777-85
99. Astrand R, Romner B, Lanke J, Unden J. Reference values for venous and capillary S100B in children. Clin Chim Acta 2011; 412:2190-3
100. Shipkova M, Wieland E. Surface markers of lymphocyte activation and markers of cell proliferation. Clin Chim Acta 2012;413: 1338-49
101. Delezuch W, Marttinen P, Kokki H, et al. Serum and CSF soluble CD26 and CD30 concentrations in healthy paediatric surgical outpatients. Tissue Antigens 2012;80:368-75
102. Albrecht L, Styne D. Laboratory testing of gonadal steroids in children. Pediatr Endocrinol Rev 2007;5:599-607
103. Srinivasan L, Shah S, Padula M, et al. Cerebrospinal fluid reference ranges in term and preterm infants in the neonatal intensive care unit. J Pediatr 2012;161:729-34
104. Shah S, Ebberson J, Kestenbaum L, et al. Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants. J Hosp Med 2011;6:22-7
105. Wong M, Schlaggar B, Buller R, et al. Cerebrospinal fluid protein concentration in paediatric patients: defining clinically relevant reference values. Arch Pediatr Adolesc Med 2000;154: 827-31 (Pubitemid 30636630)
106. Benoist JF, Alberti C, Leclercq S, et al. Cerebrospinal fluid lactate and pyruvate concentrations and their ratio in children: age-related reference intervals. Clin Chem 2003;49:487-94 (Pubitemid 36250210)
107. Zhang H, Young S, Auray-Blais C, et al. Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry. Clin Chem 2011;57: 1005-12
108. Blum WF, Englaro P, Hanitsch S, et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 1997;82:2904-10 (Pubitemid 27385646)
109. Argente J, Barrios V, Chowen JA, et al. Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosa. J Pediatr 1997;131:833-88
110. Garcia-Mayor RV, Andrade MA, Rios M, et al. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab 1997;82:2849-55 (Pubitemid 27385638)
111. Mann DR, Johnson AO, Gimpel T, Castracane VD. Changes in circulating leptin, leptin receptor, and gonadal hormones from infancy until advanced age in humans. J Clin Endocrinol Metab 2003; 88:3339-45 (Pubitemid 36877514)
112. Brandao CM, Lombardi MT, Nishida SK, et al. Serum leptin concentration during puberty in healthy nonobese adolescents. Braz J Med Biol Res 2003;36:1293-6 (Pubitemid 37322258)
113. Huang KC, Lue BH, Yen RF, et al. Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obes Res 2004;12: 119-24
114. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004;27:547-52 (Pubitemid 38174085)
115. Degawa-Yamauchi M, Dilts JR, Bovenkerk JE, et al. Lower serum adiponectin levels in African-American boys. Obes Res 2003;11: 1384-90 (Pubitemid 41127361)
116. Tsou PL, Jiang YD, Chang CC, et al. Sex related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care 2004;27:308-13
117. Kamoda T, Saitoh H, Saito M, et al. Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res 2004;56:690-3 (Pubitemid 39403391)
118. Allard P, Delvin EE, Paradis G, et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin Chem 2003;49:644-9 (Pubitemid 36379530)
119. Rogiers V. Long chain nonesterified fatty acid patterns in plasma of healthy children and young adults in relation to age and sex. J Lipid Res 1981;22:1-6 (Pubitemid 11144702)
120. Whatmore AJ, Hall CM, Jones J, et al. Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol (Oxf) 2003;59: 649-54 (Pubitemid 37357628)
121. Wong D, George K, Wilson J, et al. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure. Am J Cardiol 2011;107: 573-8.